Header cover image

U.S. Pharmaceuticals & Biotech Buy the Dip

UPDATED Aug 05, 2022

Companies which may present a buying opportunity after a dip in share price.

101 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
CHRSCoherus BioSciencesUS$11.8339.7%-9.1%US$915.9mUS$18.50PS3.3xE73.2%n/a
CTICCTI BioPharmaUS$7.4313.6%165.4%US$809.6mUS$9.79PS352.8xE67.4%n/a
FOLDAmicus TherapeuticsUS$12.1822.3%16.0%US$3.4bUS$14.50PS10.6xE69.5%n/a
OPTNOptiNoseUS$3.681.7%37.3%US$304.3mUS$7.50PS3.9xE67.6%n/a
ADMAADMA BiologicsUS$2.140%35.4%US$420.2mUS$4.50PS4.5xE67.3%n/a
ICPTIntercept PharmaceuticalsUS$16.4228.7%-1.2%US$489.3mUS$26.47PS1.3xE49.7%n/a
AVIRAtea PharmaceuticalsUS$8.797.2%-71.8%US$731.8mUS$10.25PE15.1xE45.3%n/a
CLVRClever Leaves HoldingsUS$1.0210.9%-90.4%US$40.9mUS$3.30PS2.4xE69.6%n/a
AVEOAVEO PharmaceuticalsUS$7.788.7%30.8%US$268.2mUS$16.25PS3.4xE73.0%n/a
BCRXBioCryst PharmaceuticalsUS$14.0527.5%-20.2%US$2.6bUS$16.20PS12.8xE68.9%n/a
BHVNBiohaven Pharmaceutical HoldingUS$146.980.7%18.0%US$10.4bUS$153.56PS12.1xE70.3%n/a
CASICASI PharmaceuticalsUS$2.501.2%-79.0%US$34.0mUS$37.00PS1xE73.0%n/a
VBIVVBI VaccinesUS$1.0624.6%-65.6%US$273.8mUS$6.67PS602.3xE70.2%n/a
QUREuniQureUS$25.540.7%-16.3%US$1.2bUS$51.47PE3.7xE21.9%n/a
FBIOFortress BiotechUS$1.2140.6%-63.8%US$130.0mUS$6.08PS1.6xE61.3%n/a
OPNTOpiant PharmaceuticalsUS$11.8415.3%-26.7%US$60.2mUS$40.25PS1.3xE75.5%n/a
CLNNCleneUS$3.648.7%-60.2%US$230.3mUS$14.71PE13.8xE82.5%n/a
EOLSEvolusUS$9.40-23.8%-18.7%US$527.3mUS$16.38PS4xE69.4%n/a
AUPHAurinia PharmaceuticalsUS$8.372.3%-42.0%US$1.2bUS$23.31PS13.5xE70.8%n/a
MNKDMannKindUS$4.3325.5%7.2%US$1.1bUS$5.60PS15.6xE68.2%n/a
RDHLRedHill BiopharmaUS$0.9610.3%-86.5%US$56.0mUS$7.75PE-0.6xE67.8%n/a
CORTCorcept TherapeuticsUS$28.700.1%31.5%US$3.0bUS$32.17PE27xE30.5%n/a
HZNPHorizon TherapeuticsUS$69.60-16.1%-34.3%US$16.0bUS$105.71PE21xE25.7%n/a
SLGLSol-Gel TechnologiesUS$5.884.8%-41.4%US$136.0mUS$17.67PE14.2xE50.7%n/a
Page 1 of 5